Skip to main content
Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · IEX Real-Time Price · USD
1.240
+0.070 (5.98%)
At close: Jul 26, 2024, 4:00 PM
1.196
-0.044 (-3.55%)
After-hours: Jul 26, 2024, 7:17 PM EDT

Nexalin Technology Revenue

Nexalin Technology had revenue of $78.67K in the quarter ending March 31, 2024, with 157.43% growth. This brings the company's revenue in the last twelve months to $158.86K, down -84.56% year-over-year. In the year 2023, Nexalin Technology had annual revenue of $110.75K, down -91.62%.

Revenue (ttm)
$158.86K
Revenue Growth
-84.56%
P/S Ratio
59.70
Revenue / Employee
$26,477
Employees
6
Market Cap
9.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023110.75K-1.21M-91.62%
Dec 31, 20221.32M1.18M817.20%
Dec 31, 2021144.07K-98.85K-40.69%
Dec 31, 2020242.91K35.53K17.13%
Dec 31, 2019207.38K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molecular Templates 31.76M
Zhongchao 19.43M
Syra Health 6.08M
Elevai Labs 2.18M
Organovo Holdings 109.00K
ABVC BioPharma 25.36K
Kazia Therapeutics 15.65K
Revenue Rankings

NXL News

More News